[ad_1]
This “Apheresis Market – Forecast 2021 to 2026” report added to ResearchAndMarkets.com’s supply.
The global apheresis components market is expected to grow at a CAGR of 6.78% over the forecast period, from USD 996.509 million in 2019 to reach a market size of USD 1,577.069 million in 2026.
mentioned company
-
HemaCare
-
TERUMO BCT, Inc.
-
Fresenius Medical Care AG & Co. KGaA
-
hematology company
-
Asahi Kasei Medical Co., Ltd.
-
B.Braun Melsungen AG
-
Jinhua Company
-
Michael Pharmaceuticals
-
Miltenyi Biotechnology
-
Mallinckrodt
The global apheresis market is expected to flourish over the forecast period on account of the increasing prevalence of chronic diseases and the rising number of serious injuries and trauma cases. Growing demand for blood components such as red blood cells, white blood cells, and platelets is further driving the market demand over the forecast period. Rising awareness to promote voluntary blood donation with the rise of blood donation programs further presents an opportunity to strengthen the market growth at a significant rate in the coming years. Furthermore, the increasing number of complex procedures requiring blood components or apheresis for therapeutic purposes is driving the market growth over the forecast period. In addition, the global prevalence of blood diseases is also driving the market demand over the forecast period.
Geographically, thanks to early technology adoption and advanced medical facilities with specialized treatment procedures and…
The full story is available on Benzinga.com
[ad_2]
Source link
